98 related articles for article (PubMed ID: 23315502)
1. The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
Salas A
Gut; 2013 Oct; 62(10):1392-3. PubMed ID: 23315502
[No Abstract] [Full Text] [Related]
2. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice.
Sedhom MA; Pichery M; Murdoch JR; Foligné B; Ortega N; Normand S; Mertz K; Sanmugalingam D; Brault L; Grandjean T; Lefrancais E; Fallon PG; Quesniaux V; Peyrin-Biroulet L; Cathomas G; Junt T; Chamaillard M; Girard JP; Ryffel B
Gut; 2013 Dec; 62(12):1714-23. PubMed ID: 23172891
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease.
Beltrán CJ; Núñez LE; Díaz-Jiménez D; Farfan N; Candia E; Heine C; López F; González MJ; Quera R; Hermoso MA
Inflamm Bowel Dis; 2010 Jul; 16(7):1097-107. PubMed ID: 20014018
[TBL] [Abstract][Full Text] [Related]
4. Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.
Chen WY; Hong J; Gannon J; Kakkar R; Lee RT
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7249-54. PubMed ID: 25941360
[TBL] [Abstract][Full Text] [Related]
5. IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.
Waddell A; Vallance JE; Moore PD; Hummel AT; Wu D; Shanmukhappa SK; Fei L; Washington MK; Minar P; Coburn LA; Nakae S; Wilson KT; Denson LA; Hogan SP; Rosen MJ
Inflamm Bowel Dis; 2015 Dec; 21(12):2737-46. PubMed ID: 26313694
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury.
Mato N; Fujii M; Hakamata Y; Kobayashi E; Sato A; Hayakawa M; Ohto-Ozaki H; Bando M; Ohno S; Tominaga S; Sugiyama Y
Eur Respir J; 2009 Jun; 33(6):1415-28. PubMed ID: 19196821
[TBL] [Abstract][Full Text] [Related]
7. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ
Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433
[TBL] [Abstract][Full Text] [Related]
8. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
[TBL] [Abstract][Full Text] [Related]
9. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 signaling boosts inflammation and pain.
Fattori V; Borghi SM; Verri WA
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10034-E10035. PubMed ID: 29109297
[No Abstract] [Full Text] [Related]
11. The potential role of IL-33/ST2 signaling in fibrotic diseases.
Gao Q; Li Y; Li M
J Leukoc Biol; 2015 Jul; 98(1):15-22. PubMed ID: 25881899
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways.
Saluja R; Hawro T; Eberle J; Church MK; Maurer M
J Biol Regul Homeost Agents; 2014; 28(4):575-85. PubMed ID: 25620169
[TBL] [Abstract][Full Text] [Related]
13. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
Willems S; Hoefer I; Pasterkamp G
Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
[TBL] [Abstract][Full Text] [Related]
14. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
16. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
Carriere V; Roussel L; Ortega N; Lacorre DA; Americh L; Aguilar L; Bouche G; Girard JP
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):282-7. PubMed ID: 17185418
[TBL] [Abstract][Full Text] [Related]
17. IL-20: biological functions mediated through two types of receptor complexes.
Wegenka UM
Cytokine Growth Factor Rev; 2010 Oct; 21(5):353-63. PubMed ID: 20864382
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 mediates formalin-induced inflammatory pain in mice.
Han P; Zhao J; Liu SB; Yang CJ; Wang YQ; Wu GC; Xu DM; Mi WL
Neuroscience; 2013 Jun; 241():59-66. PubMed ID: 23523996
[TBL] [Abstract][Full Text] [Related]
19. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-38 and its related cytokines in inflammation.
Yuan X; Peng X; Li Y; Li M
Mediators Inflamm; 2015; 2015():807976. PubMed ID: 25873772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
